Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations.

The Journal of clinical endocrinology and metabolism - 1 May 2017

Kim Tae Hyuk, Ki Chang-Seok, Kim Hye Seung, Kim Kyunga, Choe Jun-Ho, Kim Jung-Han, Kim Jee Soo, Oh Young Lyun, Hahn Soo Yeon, Shin Jung Hee, Jang Hye Won, Kim Sun Wook, Chung Jae Hoon

Abstract excerpt

Context: Currently, no recurrence or mortality risk systems consider molecular testing when predicting thyroid cancer outcomes. Objective: We developed an integrative prognostic system that incorporates telomerase reverse transcription (TERT) promoter mutations into the recently proposed risk reclassification system after initial therapy [dynamic risk stratification (DRS)] to better categorize and predict...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Papillary

Share to Telomerase

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Thyroidectomy

Share to Tumor Burden

Source

Identifiers

PMID: 28323925
DOI: 10.1210/jc.2016-3434

Genes

AHR
TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations.PMID 28323925Read ↗

How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?Semantic proximity Read ↗

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.Semantic proximity Read ↗

Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.Semantic proximity Read ↗

Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma.Semantic proximity Read ↗

TERT promoter mutations and long-term survival in patients with thyroid cancer.Semantic proximity Read ↗

Prognostic Stratification of Highly Differentiated Thyroid Cancer Based on Molecular Genetic Studies.Semantic proximity Read ↗

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.Semantic proximity Read ↗

Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study.Semantic proximity Read ↗

Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness.Semantic proximity Read ↗

BRAF and TERT promoter mutations: clinical application in thyroid cancer.Semantic proximity Read ↗

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.